Surgery Partners, Inc.

NasdaqGS:SGRY 주식 보고서

시가총액: US$3.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Surgery Partners 관리

관리 기준 확인 4/4

Surgery Partners' CEO는 J. Evans, Jan2020 에 임명되었습니다 의 임기는 4.42 년입니다. 총 연간 보상은 $ 6.46M, 16.3% 로 구성됩니다. 16.3% 급여 및 83.7% 보너스(회사 주식 및 옵션 포함). 는 $ 11.51M 가치에 해당하는 회사 주식의 0.36% 직접 소유합니다. 11.51M. 경영진과 이사회의 평균 재임 기간은 각각 2.9 년과 6.1 년입니다.

주요 정보

J. Evans

최고 경영자

US$6.5m

총 보상

CEO 급여 비율16.3%
CEO 임기4.5yrs
CEO 소유권0.4%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간6.2yrs

최근 관리 업데이트

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Recent updates

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Dec 06
Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

Oct 04
Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

CEO 보상 분석

J. Evans 의 보수는 Surgery Partners 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

US$600k

Dec 31 2023US$6mUS$1m

-US$12m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$6mUS$1m

-US$55m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$38m

Dec 31 2021US$4mUS$1m

-US$81m

Sep 30 2021n/an/a

-US$86m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$150m

Dec 31 2020US$4mUS$916k

-US$156m

Sep 30 2020n/an/a

-US$179m

Jun 30 2020n/an/a

-US$132m

Mar 31 2020n/an/a

-US$119m

Dec 31 2019US$5mUS$435k

-US$110m

보상 대 시장: J. 의 총 보상 ($USD 6.46M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 6.80M ).

보상과 수익: J. 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

J. Evans (47 yo)

4.5yrs

테뉴어

US$6,457,600

보상

Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...


리더십 팀

이름위치테뉴어보상소유권
Wayne DeVeydt
Executive Chairman6.5yrsUS$250.00k0.080%
$ 2.7m
J. Evans
CEO & Director4.5yrsUS$6.46m0.36%
$ 12.4m
David Doherty
Executive VP & CFO2.4yrsUS$3.52m0.076%
$ 2.6m
Jennifer Baldock
Executive VP and Chief Administrative & Development Officer4.4yrsUS$3.09m0.15%
$ 4.9m
Bradley Owens
President of National Group4.6yrsUS$1.61m0.057%
$ 1.9m
Marissa Brittenham
Executive VP & Chief Strategy Officer2.5yrsUS$1.68m0.031%
$ 1.1m
Neil Zieselman
Senior Vice President of Corporate Finance & Controller2.2yrs데이터 없음데이터 없음
Varun Gadhok
Senior VP & Chief Information Officer3yrs데이터 없음데이터 없음
Roxanne Womack
Senior VP & Chief Compliance Officer5.7yrs데이터 없음데이터 없음
Spencer Clark
General Counsel & Senior VPless than a year데이터 없음데이터 없음
Danielle Burkhalter
Executive VP & Chief Human Resources Officer1.4yrs데이터 없음0.024%
$ 815.6k
Anthony Taparo
Chief Growth Officer4.9yrsUS$1.30m0.081%
$ 2.7m

3.0yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: SGRY 의 관리팀은 경험 ( 2.9 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Wayne DeVeydt
Executive Chairman6.5yrsUS$250.00k0.080%
$ 2.7m
J. Evans
CEO & Director4.5yrsUS$6.46m0.36%
$ 12.4m
Clifford Adlerz
Director6.8yrsUS$260.00k0.040%
$ 1.4m
Blair Hendrix
Director3.2yrs데이터 없음데이터 없음
William Turner
Independent Director8.6yrsUS$285.00k0.054%
$ 1.8m
Patricia Maryland
Independent Director3.4yrsUS$260.00k0.014%
$ 476.0k
Teresa DeLuca
Independent Director7.8yrsUS$280.00k0.046%
$ 1.6m
John Deane
Independent Director5.2yrsUS$260.00k0.022%
$ 736.1k
T. O'Reilly
Director6.9yrs데이터 없음데이터 없음
Andrew Kaplan
Director5.9yrs데이터 없음데이터 없음

6.2yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: SGRY 의 이사회경험(평균 재직 기간 6.1 년)으로 간주됩니다.